VR

Venkatanarayana Reddy Jayampu

Active Director Whole-Time Director DIN 08427188
DIN 08427188 First appointment May 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since May 2019
Shareholding value •••• Premium profile

About Venkatanarayana Reddy Jayampu

Data last updated:

Venkatanarayana Reddy Jayampu is a Whole-Time Director at Apl Healthcare Limited (since 2019), Director at Auroactive Pharma Private Limited (since 2024) and Designated Partner at Service First Experts Llp (since 2023), and holds 1 more current directorship. The companies operate in Pharma, Real Estate and Construction and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹4,450 Cr; the largest is Apl Healthcare Limited at ₹4,413 Cr (FY 2025). Earlier, Venkatanarayana Reddy Jayampu was a Director at Gls Pharma Limited (2024).

DIN 08427188
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 23 May 2019
Oldest Company Age 19 yrs
Largest company Apl Healthcare Limited · ₹4,413 Cr (FY 2025)
Combined revenue ₹4,450 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apl Healthcare Limited U24239TG2006PLC052053
Whole-Time Director23 May 20192006₹4,413 Cr (FY 2025)Active
Auroactive Pharma Private Limited U24230TG2020PTC138313
Director04 Nov 20242020₹37.55 Cr (FY 2025)Active
Designated Partner07 Jul 20232023Active
Ohapra Llp AAU-9852
Designated Partner07 Dec 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gls Pharma Limited U24239TS2004PLC184306
Director22 Jan 20242004₹36.08 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Venkatanarayana Reddy Jayampu

Directorship timeline

Open interactive timeline →
Ohapra Llp
Apl Healthcare Limited
Auroactive Pharma Private Limited
Service First Experts Llp
Premium access

Shareholding and investment profile for Venkatanarayana Reddy Jayampu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkatanarayana Reddy Jayampu

Venkatanarayana Reddy Jayampu currently holds 4 directorships: Apl Healthcare Limited (Whole-Time Director, since 23 May 2019, revenue ₹4,413 Cr (FY 2025)); Auroactive Pharma Private Limited (Director, since 04 Nov 2024, revenue ₹37.55 Cr (FY 2025)); Service First Experts Llp (Designated Partner, since 07 Jul 2023); Ohapra Llp (Designated Partner, since 07 Dec 2020).

Venkatanarayana Reddy Jayampu was first appointed on 23 May 2019 as Whole-Time Director at Apl Healthcare Limited. The most recent appointment on record is 04 Nov 2024 at Auroactive Pharma Private Limited.

The 2 current companies of Venkatanarayana Reddy Jayampu that report revenue have a combined latest revenue of ₹4,450 Cr: Apl Healthcare Limited ₹4,413 Cr (FY 2025); Auroactive Pharma Private Limited ₹37.55 Cr (FY 2025).

Venkatanarayana Reddy Jayampu held 1 earlier board appointment: Gls Pharma Limited (Director, 22 Jan 2024 to 04 Nov 2024).

The current boards of Venkatanarayana Reddy Jayampu's companies include Mylandlahalli Rammohan Ashwini (Apl Healthcare Limited), Nityananda Reddy Kambam (Apl Healthcare Limited), Salgunan Komatheruvan Chettivalappil (Apl Healthcare Limited), Sivakumaran Meenakshisunderam (Apl Healthcare Limited), Suryanarayana Murthy Mula (Apl Healthcare Limited), Suryanarayana Murthy Mula (Apl Healthcare Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available